The abstract is read at the publisher; the summary is JClub's.
In a single-center cohort of 689 kidney transplant recipients, microvascular inflammation defined as first g+ptc≥2 was not independently linked to death-censored allograft loss after accounting for time-varying TCMR and dnDSA.
- Why it matters: Microvascular inflammation often appears with T-cell-mediated rejection and de novo donor-specific anti-HLA antibodies, but whether it adds independent prognostic risk when these events overlap is unclear.
- What they did: The study analyzed first occurrences of g+ptc≥2, TCMR, and de novo DSA in 689 recipients (2004–2021) using Cox models with time-dependent covariates to handle serial and concomitant events.
- The result: Individually, first g+ptc≥2 (HR 4.33, 95% CI 2.5–7.5) related to death-censored allograft loss, but in the combined time-dependent model g+ptc≥2 was not significant (HR 1.77, 95% CI 0.84–3.73), while TCMR and dnDSA remained associated.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.